Please Wait

Applying Filters...

Looking for Tasigna? Find Controlled & Modified Release used in Tasigna to address drug delivery challenges on PharmaCompass.

Tasigna

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

47 API Suppliers, 22 USDMF, 3 CEP/COS, 1 JDMF, 7 EU WC, 5 KDMF, 14 NDC API, 33 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

INTERMEDIATES

27 Intermediates Suppliers

27 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

48 FDF Dossiers, 10 FDA Orange Book, 6 Europe, 7 Australia, 2 South Africa, 23 Listed Dossiers

RELATED EXCIPIENT COMPANIES

7 DKSH, 2 Faran Shimi Pharmaceutical, 4 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 BASF, 2 DFE Pharma, 2 Gangwal Chemicals, 14 Kerry, 3 Lonza Capsugel, 7 Microlex e.U, 1 Nanjing Bold Chemical, 2 Pluviaendo, 1 Prachin Chemical, 1 Qualicaps, 2 Roquette, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 3 Sigachi Industries, 1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

30 Fillers, Diluents & Binders, 10 Lubricants & Glidants, 10 Direct Compression, 8 Empty Capsules, 7 Thickeners and Stabilizers, 5 Granulation, 5 Co-Processed Excipients, 5 Coating Systems & Additives, 4 Emulsifying Agents, 3 Film Formers & Plasticizers, 2 Coloring Agents, 2 Parenteral, 1 Controlled & Modified Release, 1 API Stability Enhancers, 1 Taste Masking, 1 Solubilizers, 1 Topical

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 1 STOCK RECAP #PipelineProspector, 42 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 3 Finished Drug Prices, 10 Annual Reports

MARKET PLACE

9 APIs, 9 FDF Dossiers

PATENTS & EXCLUSIVITIES

45 US Patents, 18 US Exclusivities, 6 Health Canada Patents

REF. STANDARDS & IMPURITIES

5 Others

5 Others

$ Xls

Filters

Tasigna

Filters

FILTER :

filter Company Reset all filters

2 All

01 2Gangwal Healthcare

filter Capability Reset all filters

filter Country Reset all filters

01

Gangwal Healthcare

India

Pharma, Lab & Chemical Expo

Not Confirmed

Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

Dosage Form : Capsule, Tablet

Grade : Oral

Brand Name : DiCOM-DC® SR300

Application : Co-Processed Excipients, Controlled & Modified Release, Direct Compression

Excipient Details : DiCOM-DC SR300 is used as a directly compressible, rate-controlling, and co-processed excipient in sustained-release tablets and capsules.

Pharmacopoeia Ref : In-house

Technical Specs : NA

Ingredient(s) : EthylCellulose, Hydroxypropyl Cellulose, Hydroxypropyl Methylcellulose, Magnesium Stearate, Maize Starch, Microcrystalline Cellulose, Silicon Dioxide, Talc

Dosage Form : Capsule, Tablet

Grade : Oral

Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

Ingredient(s) : EthylCellulose, Hydroxypropyl Cellulose, Hydroxypropyl Methylcellulose, Magnesium Stearate, Maize Starch, Microcrystalline Cellulose, Silicon Dioxide, Talc

Dosage Form : Capsule, Tablet

Category : Co-Processed Excipients, Controlled & Modified Release, Direct Compression

Brand : DICOM-DC® SR300

Applications : DiCOM-DC SR300 is used as a directly compressible, rate-controlling, and co-processed excipient in sustained-release tablets and capsules.

Pharmacopoeia Ref : In-house

Technical Specs : NA

Grade : Oral

Gangwal Healthcare DiCOM-DC® SR300

Excipients Web Link

Digital Content